Low VLDL causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 57: | Line 57: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| No underlying causes | ||
No underlying causes|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
| Line 73: | Line 73: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Parkinson's disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 168: | Line 168: | ||
*[[Abetalipoproteinemia|Mutations of the MTTP gene]] | *[[Abetalipoproteinemia|Mutations of the MTTP gene]] | ||
*[[Nicotinic acid]] | *[[Nicotinic acid]] | ||
*[[ | *[[Parkinson's disease]]<ref name="pmid24086623">{{cite journal| author=Wei Q, Wang H, Tian Y, Xu F, Chen X, Wang K| title=Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients. | journal=PLoS One | year= 2013 | volume= 8 | issue= 9 | pages= e75743 | pmid=24086623 | doi=10.1371/journal.pone.0075743 | pmc=PMC3784418 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24086623 }} </ref> | ||
*[[Transjugular intrahepatic portosystemic shunt|Portosystemic shunts]] | *[[Transjugular intrahepatic portosystemic shunt|Portosystemic shunts]] | ||
*[[Prazosin]] | *[[Prazosin]] | ||
Revision as of 17:56, 8 November 2013
|
Very Low Density Lipoprotein Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
Low VLDL causes On the Web |
|
American Roentgen Ray Society Images of Low VLDL causes |
|
Directions to Hospitals Treating Very low density lipoprotein |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Overview
Inherited disorders of lipoprotein metabolism like Abetalipoproteinemia and lipid lowering medications and diet are usually associated with low VLDL levels.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Scanu, AM.; Aggerbeck, LP.; Kruski, AW.; Lim, CT.; Kayden, HJ. (1974). "A study of the abnormal lipoproteins in abetalipoproteinemia". J Clin Invest. 53 (2): 440–53. doi:10.1172/JCI107578. PMID 11344558. Unknown parameter
|month=ignored (help) - ↑ Welty, FK.; Mittleman, MA.; Wilson, PW.; Sutherland, PA.; Matheney, TH.; Lipinska, I.; Muller, JE.; Levy, D.; Tofler, GH. (1997). "Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population". Circulation. 95 (4): 825–30. PMID 9054738. Unknown parameter
|month=ignored (help) - ↑ Kim HJ, Moon JH, Kim HM, Yun MR, Jeon BH, Lee B; et al. (2013). "The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression". Metabolism. doi:10.1016/j.metabol.2013.09.006. PMID 24139096.
- ↑ Rojas A, Del Campo JA, Maraver M, Aparcero R, García-Valdecasas M, Diago M; et al. (2013). "Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro". J Viral Hepat. doi:10.1111/jvh.12209. PMID 24188401.
- ↑ Wei Q, Wang H, Tian Y, Xu F, Chen X, Wang K (2013). "Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients". PLoS One. 8 (9): e75743. doi:10.1371/journal.pone.0075743. PMC 3784418. PMID 24086623.